Cargando…
Low‐dose oral interferon alpha as prophylaxis against viral respiratory illness: a double‐blind, parallel controlled trial during an influenza pandemic year
BACKGROUND AND OBJECTIVE: Interferon alpha (IFNα) is a known antiviral agent. A double‐blind, placebo‐controlled clinical trial was conducted investigating the use of low‐dose oral interferon alpha for preventing acute viral respiratory illnesses. METHODS: Two hundred healthy adults aged 18–75 years...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781220/ https://www.ncbi.nlm.nih.gov/pubmed/23398960 http://dx.doi.org/10.1111/irv.12094 |